Next Article in Journal
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study
Next Article in Special Issue
Nanodrug Delivery Systems for Acute Lymphoblastic Leukemia Therapy
Previous Article in Journal
Timbe (Acaciella angustissima) as an Alternative Source of Compounds with Biological Activity: Antidiabetic
Previous Article in Special Issue
Red Blood Cell-Based Delivery Systems for the Release of Hemoglobin-Derived Peptides with In Vitro Antitumor Activities
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(4), 594; https://doi.org/10.3390/ph18040594
Action Date Notes Link
article xml file uploaded 18 April 2025 16:20 CEST Original file -
article xml uploaded. 18 April 2025 16:20 CEST Update https://www.mdpi.com/1424-8247/18/4/594/xml
article pdf uploaded. 18 April 2025 16:20 CEST Version of Record https://www.mdpi.com/1424-8247/18/4/594/pdf
article html file updated 18 April 2025 16:22 CEST Original file https://www.mdpi.com/1424-8247/18/4/594/html
Back to TopTop